These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of lipid and lipoprotein profiles in risk assessment and therapy. Ballantyne CM, Hoogeveen RC. Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189 [Abstract] [Full Text] [Related]
9. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508 [Abstract] [Full Text] [Related]
10. The heart of the matter. National guidelines urge more aggressive cholesterol treatment. Leake NB. Adv Nurse Pract; 2002 Jan 15; 10(1):42-7; quiz 48-9. PubMed ID: 12420511 [No Abstract] [Full Text] [Related]
11. Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients? Moyad MA. Urol Clin North Am; 2004 May 15; 31(2):195-8. PubMed ID: 15123398 [Abstract] [Full Text] [Related]
12. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW. Chin Med J (Engl); 2004 Feb 15; 117(2):163-7. PubMed ID: 14975195 [Abstract] [Full Text] [Related]
14. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men. Nasir K, Santos RD, Roguin A, Carvalho JA, Meneghello R, Blumenthal RS. Int J Cardiol; 2006 Mar 22; 108(1):68-75. PubMed ID: 16516700 [Abstract] [Full Text] [Related]
15. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors]. Wahlberg G. Lakartidningen; 2006 Mar 22; 103(3):131-4. PubMed ID: 16465756 [No Abstract] [Full Text] [Related]
16. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol. Grover SA, Dorais M, Coupal L. Epidemiology; 2003 May 22; 14(3):315-20. PubMed ID: 12859032 [Abstract] [Full Text] [Related]
17. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ. J Am Osteopath Assoc; 2002 Jul 22; 102(7):377-84. PubMed ID: 12138952 [Abstract] [Full Text] [Related]
18. Cholesterol and coronary events. The current thinking. Jones PH. Postgrad Med; 2003 Apr 22; 113(4 Suppl):5-14. PubMed ID: 19667618 [Abstract] [Full Text] [Related]
19. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Hyre AD, Muntner P, Menke A, Raggi P, He J. Ann Epidemiol; 2007 Jul 22; 17(7):548-55. PubMed ID: 17395483 [Abstract] [Full Text] [Related]